delays, to access high-quality, interactive therapy experiences in familiar and engaging environments.

Founded in August 2022, VIZQ leverages patented technology to extend a licensed Speech-Language Pathologist’s (SLP) plan of care, enabling unlimited follow-up treatments without requiring the physical presence of an SLP. Designed as a Software as a Medical Device (SaMD), VizQ.AI uses biofeedback, adaptive prompting, and gamified activities to deliver measurable therapeutic outcomes.

VIZQ is committed to addressing the needs of underserved and underprivileged children in rural and metropolitan areas who often go untreated or under-treated due to barriers in access to traditional therapy services. By harnessing technology to bridge these gaps, VIZQ ensures that every child, regardless of location or socioeconomic status, has the opportunity to achieve their developmental potential.